Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)

Chak Sing Lau, Yi Hsing Chen, Keith Lim, Marc de Longueville, Catherine Arendt, Kevin Winthrop

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original published version of the above article contained an error.

Original languageEnglish (US)
Pages (from-to)3161
Number of pages1
JournalClinical Rheumatology
Volume39
Issue number10
DOIs
StatePublished - Oct 1 2020

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data (Clinical Rheumatology, (2020), 10.1007/s10067-020-05248-4)'. Together they form a unique fingerprint.

Cite this